<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39453377</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>27</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2979-9139</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><Issue>5</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>02</Day></PubDate></JournalIssue><Title>Thoracic research and practice</Title><ISOAbbreviation>Thorac Res Pract</ISOAbbreviation></Journal><ArticleTitle>Clinical Course of Coronavirus disease 2019 C-19 in Patients with Bronchiectasis.</ArticleTitle><Pagination><StartPage>184</StartPage><EndPage>187</EndPage><MedlinePgn>184-187</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.5152/ThoracResPract.2024.23054</ELocationID><Abstract><AbstractText Label="OBJECTIVE">Coronavirus disease 2019 (COVID-19) has affected the whole world and caused the death of more than 6 million people. The disease has been observed to have a more severe course in patients with chronic lung diseases. There are limited data regarding COVID-19 in patients with bronchiectasis. The aim of this article is to investigate the course of COVID-19 and factors affecting the clinical outcome in patients with bronchiectasis.</AbstractText><AbstractText Label="MATERIAL AND METHODS">This study was conducted using the Turkish Adult Bronchiectasis Database (TEBVEB) to which 25 centers in Türkiye contributed between March 2019 and January 2022. The database consisted of 1035 patients, and COVID-19-related data were recorded for 606 patients.</AbstractText><AbstractText Label="RESULTS">One hundred nineteen (19.6%) of the bronchiectasis patients (64 female, mean age 57.3 ± 13.9) had COVID-19. Patients with bronchiectasis who developed COVID-19 more frequently had other comorbidities (P = .034). They also more frequently had cystic bronchiectasis (P = .009) and their Bronchiectasis Severity Index was significantly higher (P = .019). Eighty-two (68.9%) of the patients who had COVID-19 were followed up in the outpatient clinic, 27 (22.7%) in the inpatient ward and 10 (8.4%) patients in the intensive care unit. There tended to be a higher percentage of males among patients admitted to the hospital (P = .073); similarly, the mean age of the patients admitted to the hospital was also higher (60.8 vs 55.8 years for the outpatients), but these differences did not reach statistical significance (P = .071).</AbstractText><AbstractText Label="CONCLUSION">In conclusion, this study showed that severe bronchiectasis, presence of cystic bronchiectasis and worse Bronchiectasis Severity Index are associated with the development of COVID-19, but not with the severity of infection.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Çakır Edis</LastName><ForeName>Ebru</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Pulmoner Medicine, Trakya University Faculty of Medicine, Edirne, Türkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Çilli</LastName><ForeName>Aykut</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Pulmoner Medicine, Akdeniz University Faculty of Medicine, Antalya, Türkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kızılırmak</LastName><ForeName>Deniz</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Pulmoner Medicine, Manisa Celal Bayar University Faculty of Medicine, Manisa, Türkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Şakar Coşkun</LastName><ForeName>Ayşın</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Pulmoner Medicine, Manisa Celal Bayar University Faculty of Medicine, Manisa, Türkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sayıner</LastName><ForeName>Abdullah</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Pulmonology, İzmir University of Economics Faculty of Medicine, İzmir, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Çiçek</LastName><ForeName>Sedat</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Pulmoner Medicine, Akdeniz University Faculty of Medicine, Antalya, Türkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gülmez</LastName><ForeName>İnci</ForeName><Initials>İ</Initials><AffiliationInfo><Affiliation>Department of Chest Diseases, Erciyes University School of Medicine, Kayseri, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Çoban Ağca</LastName><ForeName>Meltem</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Süreyyapaşa Chest Diseases and Chest Surgery Training and Research Hospital, İstanbul, Türkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Çağlayan</LastName><ForeName>Benan</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Pulmoner Medicine, Koç University Faculty of Medicine, İstanbul, Türkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Özçelik</LastName><ForeName>Neslihan</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Pulmoner Medicine, Recep Tayyip Erdogan University Faculty of Medicine, Rize, Türkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Köktürk</LastName><ForeName>Nurdan</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Pulmoner Medicine, Gazi University Faculty of Medicine, Ankara, Türkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ocaklı</LastName><ForeName>Birsen</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Süreyyapaşa Chest Diseases and Chest Surgery Training and Research Hospital, İstanbul, Türkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Uçan</LastName><ForeName>Eyüp Sabri</ForeName><Initials>ES</Initials><AffiliationInfo><Affiliation>Dokuz Eylül Üniversitesi Tıp Fakültesi, Göğüs Hastalıkları Anabilim Dalı, İzmir, Türkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>TEBVEB researchers</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Turkey</Country><MedlineTA>Thorac Res Pract</MedlineTA><NlmUniqueID>9918609982606676</NlmUniqueID><ISSNLinking>2979-9139</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">bronchiectasis</Keyword><Keyword MajorTopicYN="N">disease severity</Keyword></KeywordList><CoiStatement><b>Declaration of Interests:</b> The authors have no conflicts of interest to declare.</CoiStatement><InvestigatorList><Investigator ValidYN="Y"><LastName>Günlüoğlu</LastName><ForeName>Gülşah</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Niksarlıoğlu</LastName><ForeName>Yelda</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zamani</LastName><ForeName>Adil</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Berk</LastName><ForeName>Serdar</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Argun Barış</LastName><ForeName>Serap</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Başyiğit</LastName><ForeName>İlknur</ForeName><Initials>İ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gülhan</LastName><ForeName>Pınar Yıldız</ForeName><Initials>PY</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kabak</LastName><ForeName>Mehmet</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Çolak</LastName><ForeName>Mustafa</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Baydar Toprak</LastName><ForeName>Oya</ForeName><Initials>O</Initials></Investigator><Investigator ValidYN="Y"><LastName>Berk</LastName><ForeName>Huriye</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Oğuzülgen</LastName><ForeName>Kıvılcım</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Demirdöğen</LastName><ForeName>Ezgi</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Öner Eyüboğlu</LastName><ForeName>Füsun</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Havlucu</LastName><ForeName>Yavuz</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>Babayiğit</LastName><ForeName>Cenk</ForeName><Initials>C</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>25</Day><Hour>12</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>25</Day><Hour>12</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>25</Day><Hour>10</Hour><Minute>37</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39453377</ArticleId><ArticleId IdType="pmc">PMC11391223</ArticleId><ArticleId IdType="doi">10.5152/ThoracResPract.2024.23054</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Available at: www.covid19.who.int. Date of Access: 18.9.2022.</Citation></Reference><Reference><Citation>Ejaz H, Alsrhani A, Zafar A, et al. COVID-19 and comorbidities: deleterious impact on infected patients. J Infect Public Health. 2020;13(12):1833 1839. (10.1016/j.jiph.2020.07.014)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jiph.2020.07.014</ArticleId><ArticleId IdType="pmc">PMC7402107</ArticleId><ArticleId IdType="pubmed">32788073</ArticleId></ArticleIdList></Reference><Reference><Citation>Çakır Edis E. Chronic pulmonary diseases and COVID-19. Turk Thorac J. 2020;21(5):345 349. (10.5152/TurkThoracJ.2020.20091)</Citation><ArticleIdList><ArticleId IdType="doi">10.5152/TurkThoracJ.2020.20091</ArticleId><ArticleId IdType="pmc">PMC7544403</ArticleId><ArticleId IdType="pubmed">33031727</ArticleId></ArticleIdList></Reference><Reference><Citation>Leung JM, Niikura M, Yang CWT, Sin DD. COVID-19 and COPD. Eur Respir J. 2020;56(2):2002108. (10.1183/13993003.02108-2020)</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.02108-2020</ArticleId><ArticleId IdType="pmc">PMC7424116</ArticleId><ArticleId IdType="pubmed">32817205</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheikh D, Tripathi N, Chandler TR, et al. Clinical outcomes in patients with COPD hospitalized with SARS-CoV-2 versus non-SARS-CoV-2 community-acquired pneumonia. Respir Med. 2022;191:106714. (10.1016/j.rmed.2021.106714)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rmed.2021.106714</ArticleId><ArticleId IdType="pmc">PMC8654722</ArticleId><ArticleId IdType="pubmed">34915396</ArticleId></ArticleIdList></Reference><Reference><Citation>Martínez-Vergara A, Girón Moreno RM, Olveira C, et al. Impact of the SARS-CoV-2 Virus Pandemic on patients with Bronchiectasis: a multicenter Study. Antibiotics (Basel). 2022;11(8):1096. (10.3390/antibiotics11081096)</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antibiotics11081096</ArticleId><ArticleId IdType="pmc">PMC9405473</ArticleId><ArticleId IdType="pubmed">36009967</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi H, Lee H, Lee SK, et al. Impact of bronchiectasis on susceptibility to and severity of COVID-19: a nationwide cohort study. Ther Adv Respir Dis. 2021;15:1753466621995043. (10.1177/1753466621995043)</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1753466621995043</ArticleId><ArticleId IdType="pmc">PMC7890711</ArticleId><ArticleId IdType="pubmed">33583345</ArticleId></ArticleIdList></Reference><Reference><Citation>Borekci S, Vardaloglu I, Gungordu N, et al. Treatment adherence and anxiety levels of bronchiectasis patients in the COVID-19 pandemic. Med (Baltim). 2023;102(19):e33716. (10.1097/MD.0000000000033716)</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000033716</ArticleId><ArticleId IdType="pmc">PMC10173943</ArticleId><ArticleId IdType="pubmed">37171358</ArticleId></ArticleIdList></Reference><Reference><Citation>Chalmers JD, Goeminne P, Aliberti S, et al. The bronchiectasis severity index. An international derivation and validation study. Am J Respir Crit Care Med. 2014;189(5):576 585. (10.1164/rccm.201309-1575OC)</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201309-1575OC</ArticleId><ArticleId IdType="pmc">PMC3977711</ArticleId><ArticleId IdType="pubmed">24328736</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang X, Li S, Yu H, et al. Epidemiological, comorbidity factors with severity and prognosis of COVID-19: a systematic review and meta-analysis. Aging. 2020;12(13):12493 12503. (10.18632/aging.103579)</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/aging.103579</ArticleId><ArticleId IdType="pmc">PMC7377860</ArticleId><ArticleId IdType="pubmed">32658868</ArticleId></ArticleIdList></Reference><Reference><Citation>Chalmers JD, Chang AB, Chotirmall SH, Dhar R, McShane PJ. Bronchiectasis. Nat Rev Dis Primers. 2018;4(1):45. (10.1038/s41572-018-0042-3)</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41572-018-0042-3</ArticleId><ArticleId IdType="pubmed">30442957</ArticleId></ArticleIdList></Reference><Reference><Citation>O’Donnell AE. Bronchiectasis- A clinical review. N Engl J Med. 2022;387(6):533 545. (10.1056/NEJMra2202819)</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra2202819</ArticleId><ArticleId IdType="pubmed">35947710</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao Y-H, Guan W-J, Xu G, et al. The role of viral infection in pulmonary exacerbations of bronchiectasis in adults: a prospective study. Chest. 2015;147(6):1635 1643. (10.1378/chest.14-1961)</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.14-1961</ArticleId><ArticleId IdType="pmc">PMC7094490</ArticleId><ArticleId IdType="pubmed">25412225</ArticleId></ArticleIdList></Reference><Reference><Citation>Crichton ML, Shoemark A, Chalmers JD. The impact of the COVID-19 pandemic on exacerbations and symptoms in bronchiectasis: a prospective study. Am J Respir Crit Care Med. 2021;204(7):857 859. (10.1164/rccm.202105-1137LE)</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202105-1137LE</ArticleId><ArticleId IdType="pmc">PMC8528525</ArticleId><ArticleId IdType="pubmed">34265234</ArticleId></ArticleIdList></Reference><Reference><Citation>Kokturk N, Babayigit C, Kul S, et al. The predictors of COVID-19 mortality in a nationwide cohort of Turkish patients. Respir Med. 2021;183:106433. (10.1016/j.rmed.2021.106433)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rmed.2021.106433</ArticleId><ArticleId IdType="pmc">PMC8079263</ArticleId><ArticleId IdType="pubmed">33957434</ArticleId></ArticleIdList></Reference><Reference><Citation>Uzun O, Akpolat T, Varol A, et al. COVID19: vaccination vs. hospitalization. Infection. 2022;50(3):747 752. (10.1007/s15010-021-01751-1)</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-021-01751-1</ArticleId><ArticleId IdType="pmc">PMC8725959</ArticleId><ArticleId IdType="pubmed">34984646</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>